- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-fibrotic Potential of AT2 Receptor Agonists
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-08-31
DOI
10.3389/fphar.2017.00564
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain
- (2017) Jan Keppel Hesselink et al. Journal of Pain Research
- Update on angiotensin AT2 receptors
- (2016) Robert M. Carey CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
- (2016) Chirag Bavishi et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Compound 21, a selective agonist of angiotensin AT2receptors, prevents endothelial inflammation and leukocyte adhesionin vitroandin vivo
- (2015) Amanda K Sampson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Selective activation of angiotensin AT2receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
- (2015) E Bruce et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hypertension: Renin-Angiotensin-Aldosterone System Alterations
- (2015) L. te Riet et al. CIRCULATION RESEARCH
- β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats
- (2015) Mark Del Borgo et al. CLINICAL SCIENCE
- AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy
- (2015) C. Koulis et al. HYPERTENSION
- A Nonpeptide Angiotensin II Type 2 Receptor Agonist Prevents Renal Inflammation in Early Diabetes
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Fibrosis — A Common Pathway to Organ Injury and Failure
- (2015) Don C. Rockey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relative affinity of angiotensin peptides and novel ligands at AT1and AT2receptors
- (2015) Sanja Bosnyak et al. CLINICAL SCIENCE
- Differential Effects of β-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells
- (2015) Abuzar Mahmood et al. PLoS One
- Effects of Cardiac Overexpression of the Angiotensin II Type 2 Receptor on Remodeling and Dysfunction in Mice Post–Myocardial Infarction
- (2014) Jiang Xu et al. HYPERTENSION
- Therapeutic Targets in Heart Failure
- (2014) Erik B. Schelbert et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
- (2014) Bryna S. Man Chow et al. KIDNEY INTERNATIONAL
- Saralasin and Sarile Are AT2 Receptor Agonists
- (2014) Marie-Odile Guimond et al. ACS Medicinal Chemistry Letters
- Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle
- (2013) Paula Painemal et al. BIOFACTORS
- Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart
- (2013) Dilyara Lauer et al. HYPERTENSION
- Renin Inhibition and AT1R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling
- (2013) Adam Whaley-Connell et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
- (2013) H. Makani et al. BMJ-British Medical Journal
- Strategies for anti-fibrotic therapies
- (2012) Joel Rosenbloom et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Update on the Angiotensin AT2 Receptor
- (2012) Claudia A. McCarthy et al. CURRENT HYPERTENSION REPORTS
- Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients
- (2012) L. C. van Vark et al. EUROPEAN HEART JOURNAL
- Direct Angiotensin II Type 2 Receptor Stimulation in N ω -Nitro- l -Arginine-Methyl Ester–Induced Hypertension
- (2012) Ludovit Paulis et al. HYPERTENSION
- Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism
- (2012) Koen Verdonk et al. HYPERTENSION
- Myofibroblast-mediated mechanisms of pathological remodelling of the heart
- (2012) Karl T. Weber et al. Nature Reviews Cardiology
- Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury
- (2011) Yanfei Qi et al. EXPERIMENTAL PHYSIOLOGY
- A Single β-Amino Acid Substitution to Angiotensin II Confers AT 2 Receptor Selectivity and Vascular Function
- (2011) Emma S. Jones et al. HYPERTENSION
- Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats
- (2011) Asia Rehman et al. HYPERTENSION
- cGMP Inhibits TGF-β Signaling by Sequestering Smad3 with Cytosolic β2-Tubulin in Pulmonary Artery Smooth Muscle Cells
- (2011) Kaizheng Gong et al. MOLECULAR ENDOCRINOLOGY
- Of fads, fashion, surrogate endpoints and dual RAS blockade
- (2010) F. H. Messerli et al. EUROPEAN HEART JOURNAL
- Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
- (2010) Franziska Rompe et al. HYPERTENSION
- Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
- (2010) Luis C. Matavelli et al. HYPERTENSION
- Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage
- (2009) Paolo Gelosa et al. JOURNAL OF HYPERTENSION
- Angiotensin II Type 2 Receptor Stimulation
- (2008) Elena Kaschina et al. CIRCULATION
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- AT2 receptors: Functional relevance in cardiovascular disease
- (2008) Emma S. Jones et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started